Effects of the adenosine A1 receptor allosteric modulators PD 81,723 and LUF 5484 on the striatal acetylcholine release

European Journal of Pharmacology

Volumn 454, Issue 2-3, 2002, Pages 177-182

  Bueters, Tjerk J H ^a,b   Van Helden, Herman P M ^a   Danhof, Meindert ^b   IJzerman, Ad P ^b  

^a TNO   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Acetylcholine release; Adenosine A1 receptor; Allosteric modulation; Microdialysis; PD 81,723; Striatum

Indexed keywords

(2 AMINO 4,5,6,7 TETRAHYDROBENZ[B]THIOPHEN 3 YL)(3,4 DICHLOROPHENYL)METHANONE; 2 AMINO 3 (3,4 DICHLOROBENZOYL) 4,5,6,7 TETRAHYDROBENZO[B]THIOPHENE; 2 AMINO 4,5 DIMETHYL 3 (3 TRIFLUOROMETHYLBENZOYL)THIOPHENE; 6 N CYCLOPENTYL 9 METHYLADENINE; 6 N CYCLOPENTYLADENOSINE; 8 CYCLOPENTYLTHEOPHYLLINE; ACETYLCHOLINE; ADENINE DERIVATIVE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A1 RECEPTOR ANTAGONIST; N 0804; PD 81 723; UNCLASSIFIED DRUG; ADENOSINE RECEPTOR; THIOPHENE DERIVATIVE;

ACETYLCHOLINE RELEASE; ALLOSTERISM; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; DOSE RESPONSE; METABOLISM; PHYSIOLOGY; SECRETION; WISTAR RAT;

ACETYLCHOLINE; ALLOSTERIC REGULATION; ANIMALS; CORPUS STRIATUM; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P1; THIOPHENES;

EID: 0037111366     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02494-9     Document Type: Article

References (26)

1. Berman R.F., Fredholm B.B., Aden U., O'Connor W.T. Evidence for increased dorsal hippocampal adenosine release and metabolism during pharmacologically induced seizures in rats. Brain Res. 872:2000;44-53.
2. 1 receptor binding and function by 2-amino-3-benzoylthiophenes. Mol. Pharmacol. 38:1990;939-949.
3. 1 receptor-mediated inhibition of acetylcholine release with low efficacy agonists. Drug Dev. Res. 50:2000;81.
4. 1 receptor enhancer, PD 81,723, and cerebral ischemia/reperfusion injury in the gerbil. Gen. Pharmacol. 26:1995;1545-1548.
5. 1 receptors. J. Pharmacol. Exp. Ther. 273:1995;637-642.
6. Damsma G., Westerink B.H., De Vries J.B., Van den Berg C.J., Horn A.S. Measurement of acetylcholine release in freely moving rats by means of automated intracerebral dialysis. J. Neurochem. 48:1987;1523-1528.
7. Dunwiddie T.V., Masino S.A. The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci. 24:2001;31-55.
8. Geiger J.D., LaBella F.S., Nagy J.I. Ontogenesis of adenosine receptors in the central nervous system of the rat. Brain Res. 315:1984;97-104.
9. 1 receptor binding reduces hypoxic-ischemic brain injury in newborn rats. Brain Res. 759:1997;309-312.
10. Janusz C.A., Berman R.F. The adenosine binding enhancer, PD 81,723, inhibits epileptiform bursting in the hippocampal brain slice. Brain Res. 619:1993;131-136.
11. Janusz C.A., Bruns R.F., Berman R.F. Functional activity of the adenosine binding enhancer, PD 81,723, in the in vitro hippocampal slice. Brain Res. 567:1991;181-187.
12. 1 receptor allosteric enhancer PD 81,723 on agonist binding to brain and adipocyte membranes. Brain Res. 840:1999;75-83.
13. 3H]acetylcholine release. J. Neurochem. 62:1994;960-966.
14. 1 receptor. J. Pharmacol. Exp. Ther. 281:1997;761-768.
15. 1 receptors. Drug Dev. Res. 49:2000;227-237.
16. Marangos P.J., Patel J., Stivers J. Ontogeny of adenosine binding sites in rat forebrain and cerebellum. J. Neurochem. 39:1982;267-270.
17. Materi L.M., Rasmusson D.D., Semba K. Inhibition of synaptically evoked cortical acetylcholine release by adenosine: an in vivo microdialysis study in the rat. Neuroscience. 97:2000;219-226.
18. 6-cyclopentyladenosine in the rat. J. Pharmacol. Exp. Ther. 268:1994;616-624.
19. Moor E., Schirm E., Jacso J., Westerink B.H.C. Effects of neostigmine and atropine on basal and handling-induced acetylcholine output from ventral hippocampus. Neuroscience. 82:1998;819-825.
20. 1 receptor-dependent and -independent effects of the allosteric enhancer PD 81,723. Mol. Pharmacol. 288:1999;446-454.
21. Pardridge W.M., Yoshikawa T., Kang Y.S., Miller L.P. Blood-brain barrier transport and brain metabolism of adenosine and adenosine analogs. J. Pharmacol. Exp. Ther. 268:1994;14-18.
22. Pedata F., Giovannelli L., De Sarno P., Pepeu G. Effect of adenosine, adenosine derivatives, and caffeine on acetylcholine release from brain synaptosomes: interaction with muscarinic autoregulatory mechanisms. J. Neurochem. 46:1986;1593-1598.
23. Soudijn W., Van Wijngaarden I., IJzerman A.P. Allosteric modulation of G-protein-coupled receptors. Expert Opin. Ther. Pat. 11:2001;1889-1904.
24. 1 receptor agonists in rats: prediction of tissue-dependent efficacy in vivo. J. Pharmacol. Exp. Ther. 290:1999;702-709.
25. 1 receptor. Synthesis and biological evaluation of novel 2-amino-3-benzoylthiophenes as allosteric enhancers of agonist binding. J. Med. Chem. 42:1999;3629-3635.
26. Van Helden H.P., Bueters T.J. Protective activity of adenosine receptor agonists in the treatment of organophosphate poisoning. Trends Pharmacol. Sci. 20:1999;438-441.